Kenney J., Marinelli L., Woodarad H.
Traser studies with radioactive phosphorus in
malignant neoplastic disease // Radiology. — 1941. — V. 37. — P. 683 687.
Ketning A.
Sm 13 EDTMP and rhenium 186 HEDP as bone therapeutic radio
pharmaceuticals // Int. J. Rad. Appl. Instrum. (B). — 1987. — V. 14. — P. 223 232.
Khansur T., Haick A., Patel B., Balducci L., Vance R., Thigpen T.
Evaluation of bone
scan as a screening work up in primary and loco regional reccurence of breast cancer //
Am. J. Clin. Oncol. — 1987. — V. 10. — P. 167 170.
Kimmick G., Muss H.B.
Current status of endocrine therapy for metastatic breast
cancer // Oncology. — 1995. — V. 9. — P. 877 890.
Kitazawa S., Maeda S.
Development of skeletal metastases // Clin. Orthop. — 1995. —
V. 312. — P. 45 50.
Klein D.C., Raisz L.G.
Prostaglandins: stimulation of bone resorption in tissue cul
ture // Endocrinology. — 1970. — V. 80. — P. 1436 1440.
Koendel P.G., Beex L.V., Kloppenbord P.W., Smart A.G.
Human breast cancer: sur
vival from first metastases // Breast Cancer Study Group Breast Cancer Treat. — 1992. —
V. 21 (3). — P. 173 180.
Koizumi M., Yamada Y., Takiguchi T.
Bone metabolic markers in bone metastases //
J. Cancer Res. Clin. Oncol. — 1995. — V.121 (9 10). — P.542 548.
Koizumi K., Arbab A.S., Toyama K., Shirasu M., Osawa S., Araki T., Yamaguchi M.,
Onishi H., Araki T., Arai T., Komatsu H., Ueno A., Nokata H.
89Sr Therapy for pain relief
in patients with bone metastases // Kaku Igaku. — 1996. — V. 33(11). — P. 1243 1248.
Koizumi M., Matsumoto S., Takahashi S., Yamashita T., Ogata E.
Bone metabolic
markers in the evaluation of bone scan flare phenomenon in bone metastases of breast can
cer // Clin. Nucl. Med. — 1999. — V. 24(1). — P.15 20.
Kokron O.
Skelett metastasa sierends. Mammakarzinom in der menopause // Ltsch.
Z. Oncol. — 1989. — V.21. — P.16.
Kolbl O., Kiricuta I.C., Willner J., Flentje M.
Bone metastasis in breast carcinoma //
Zentralbl. Chir. — 1997. — V. 122(2). — P. 97 102.
Komaki R., Donegan W., Mandi E.
Prognostic value of pretreatment bone scans in
breast carcinoma // Am. J. R. — 1974. — V. 16. —¹ 4. — P. 191 193.
Koscick R.L., Petersilge C.A., Makley J.T., Abdul+Karim F.W.
CT guided fine needle
aspiration and needle core biopsy of skeletal lesions. Complementary diagnostic tech
niques // Acta Cytol. — 1998. — V. 42(3). — P. 697 702.
Koyama M.
Clinical usefulness of 201Tl chloride scintigraphy for the diagnosis of
bone metastases // Kaku Igaku. — 1995. — V.32(1). — P. 9 18.
Krieger G., Wandwer H., Kneba M.
è ñîàâò. Metastatic breast cancer with constant
ly low CEA blood levels. A sub group with unfavorable prognosis // J. cancer Res. and
Clin. Oncol. — 1984. — V. 108(3). — P. 341 344.
Krishna B.A.
Role of bone scintifraphy in the management of patients with carcino
ma of breast // Indian J. Cancer. — 1982. — V. 19(1). — P. 47 50.
Krol R., Gusta A.
Use of bone cements with added methotrexate for stabilization of
pathologic fractures and filling of long bone defects in cases of neoplasmmetastasis // Chir.
Narzadow. Ruchu. Ortop. Pol. — 1998. — V. 63(1). — P. :73 80.
Kukreja S.C., Shavin D.H., Wimbiscus S., Ebeling P.R., Wood W.I., Martin T.J.
Antibodies to parathyroid hormone related protein lower serm calcium in athymic mouse
models of malignancy associated hypercalcemia // J. Clin Invest. — 1988. — V. 82. —
P. 1798 1802.
234
Êîñòíûå ìåòàñòàçû ðàêà ìîëî÷íîé æåëåçû
